Furthermore, SREBP2 interacts with transcription factor CP2 (TFCP2) in pancreatic cancer cells, allowing them to overcome KRAS mutation-induced senescence (Zhang D. et al., 2021). Here, TFCP2 is linked to pancreatic neoplasm.